Prot #TARGET-DERM: A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions

Project: Research project

Project Details

StatusActive
Effective start/end date6/10/196/10/24

Funding

  • TARGET PharmaSolutions, Inc. (Prot #TARGET-DERM)